-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Outperform on Pharvaris, Maintains $42 Price Target

Benzinga·09/08/2026 13:20:42
Listen to the news
Wedbush analyst Laura Chico reiterates Pharvaris (NASDAQ:PHVS) with a Outperform and maintains $42 price target.